← 治験一覧に戻る
テリパラチドが股関節骨折の治癒に及ぼす影響
基本情報
- NCT ID
- NCT01473589
- ステータス
- 完了
- 試験のフェーズ
- 第3相
- 試験タイプ
- 介入
- 目標被験者数
- 122
- 治験依頼者名
- Eli Lilly and Company
概要
The purpose of this study is to see whether teriparatide, given for 6 months versus placebo, will improve the healing of hip (femoral neck) fractures that are repaired during surgery using certain types of orthopedic screws. The study will enroll men and postmenopausal women at least 50 years of age with a recent hip (femoral neck) fracture caused by low-trauma (for example, fall from standing height or less).
対象疾患
Femur Neck Fracture
介入
Teriparatide(DRUG)
Placebo(DRUG)
Calcium supplementation(DIETARY_SUPPLEMENT)
Vitamin D supplementation(DIETARY_SUPPLEMENT)
依頼者（Sponsor）
日本イーライリリー株式会社(INDUSTRY)